[{"label": "0", "tokenized": "combin of two viru fight drug ha prove consider more effect against chronic hepat infect than the standard singl medicin", "origin": "A combination of two virus fighting drugs has proved considerably more effective against chronic hepatitis C infections than the standard single medicine"}, {"label": "0", "tokenized": "nearli 100 million peopl worldwid , includ 4 million american , are believ to be have hepat the viru is blame for about 10,000 death year in the unit state and is the lead caus of chronic liver diseas and the no", "origin": "Nearly 100 million people worldwide, including 4 million Americans, are believed to be have hepatitis C The virus is blamed for about 10,000 deaths a year in the United States and is the leading cause of chronic liver disease and the No"}, {"label": "0", "tokenized": "until recent , interferon wa the onli treatment", "origin": "Until recently, interferon was the only treatment"}, {"label": "0", "tokenized": "typic , onli 15 percent to 20 percent of patient who get interferon are rid of all sign of the viru", "origin": "Typically, only 15 percent to 20 percent of patients who get interferon are rid of all signs of the virus"}, {"label": "0", "tokenized": "most patient treat with interferon eventu relaps", "origin": "Most patients treated with interferon eventually relapse"}, {"label": "0", "tokenized": "earlier thi year , the us food and drug administr approv new approach , combin of interferon and ribavirin", "origin": "Earlier this year, the US Food and Drug Administration approved a new approach, a combination of interferon and ribavirin"}, {"label": "0", "tokenized": "it is be market as rebetron by schere plough , which paid for two studi publish in thursday 's new england journal of medicin", "origin": "It is being marketed as Rebetron by Schering Plough, which paid for two studies published in Thursday's New England Journal of Medicine"}, {"label": "0", "tokenized": "in an accompani editori , dr jake liang of the nation institut of health said the result show that `` combin therapi repres an import advanc ''", "origin": "In an accompanying editorial, Dr T Jake Liang of the National Institutes of Health said the results show that \"combination therapy represents an important advance\""}, {"label": "0", "tokenized": "howev , liang caution that question remain about how long the benefit will last , as well as about such potenti seriou side effect as anemia", "origin": "However, Liang cautioned that questions remain about how long the benefits will last, as well as about such potentially serious side effects as anemia"}, {"label": "0", "tokenized": "the combin can also produc birth defect , so all user must take birth control dure and after treatment", "origin": "The combination can also produce birth defects, so all users must take birth control during and after treatment"}, {"label": "0", "tokenized": "one of the studi , led by dr john mchutchison of the scripp clinic and research foundat in la jolla , california , compar the effect of the combin with interferon alon in the initi treatment of 912 patient", "origin": "One of the studies, led by Dr John G McHutchison of the Scripps Clinic and Research Foundation in La Jolla, California, compared the effects of the combination with interferon alone in the initial treatment of 912 patients"}, {"label": "0", "tokenized": "all sign of the viru disappear in 38 percent of patient who had been given both drug for 11 month , compar with 13 percent of those treat with onli interferon", "origin": "All signs of the virus disappeared in 38 percent of patients who had been given both drugs for 11 months, compared with 13 percent of those treated with only interferon"}, {"label": "1", "tokenized": "howev , more patient who receiv the new therapi suffer from side effect , which includ difficulti breath , sore throat , rash , itch , nausea , insomnia and anorexia", "origin": "However, more patients who received the new therapy suffered from side effects, which included difficulty breathing, sore throat, rashes, itching, nausea, insomnia and anorexia"}, {"label": "0", "tokenized": "the second studi , lead by dr gari davi of the univers of florida colleg of medicin , look at 345 chronic hepat patient who had alreadi relaps after interferon treatment", "origin": "The second study, lead by Dr Gary L Davis of the University of Florida College of Medicine, looked at 345 chronic hepatitis patients who had already relapsed after interferon treatment"}, {"label": "0", "tokenized": "they were randomli assign to get either more interferon or the two drug combin", "origin": "They were randomly assigned to get either more interferon or the two drug combination"}, {"label": "0", "tokenized": "when treatment stop after six month , all sign of the viru were gone in 82 percent on combin therapi , compar with half on interferon alon", "origin": "When treatment stopped after six months, all signs of the virus were gone in 82 percent on combination therapy, compared with half on interferon alone"}, {"label": "0", "tokenized": "after anoth six month had gone by , the viru wa still undetect in half of the combin patient , compar with just 5 percent in the interferon group", "origin": "After another six months had gone by, the virus was still undetectable in half of the combination patients, compared with just 5 percent in the interferon group"}]